Cleared Traditional

K131351 - ACE ALKALINE PHOSPHATASE REAGENT, AMYLASE REAGENT, ALT REAGENT, AST REAGENT

K131351 is an FDA 510(k) clearance for ACE ALKALINE PHOSPHATASE REAGENT, manufactured by Alfa Wassermann Diagnostic Technologies, LLC. The device is a Class 2 Chemistry device with product code CJE cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K131351 · Alfa Wassermann Diagnostic Technologies, LLC · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2013
Decision
97d
Days
Class 2
Risk

K131351 is an FDA 510(k) clearance for the ACE ALKALINE PHOSPHATASE REAGENT, AMYLASE REAGENT, ALT REAGENT, AST REAGENT. Classified as Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes (product code CJE), Class II - Special Controls.

Submitted by Alfa Wassermann Diagnostic Technologies, LLC (West Caldwell, US). The FDA issued a Cleared decision on August 15, 2013 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1050 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K131351

510(k) Number K131351 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2013
Decision Date August 15, 2013
Days to Decision 97 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 88d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CJE Device Classification - Class 2, Special Controls

Product Code CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes

All 118
Devices cleared under the same product code (CJE) and FDA review panel - the closest regulatory comparables to K131351.
Comprehensive Metabolic Panel, skyla Clinical Chemistry Analyzer, Minicare C300 Clinical Chemistry Analyzer
K171971 · Lite-On Technology Corp. H.S.P.B. · Jan 2018
ALP IFCC Gen.2
K171080 · Roche Diagnostics Operations (Rdo) · May 2017
Randox RX Daytona Plus Alkaline Phosphatase (ALP)
K162275 · Randox Laboratories Limited · Apr 2017
S TEST REAGENT CARTRIDGE ALP (ALKALINE PHOSPHATASE)
K130141 · Hitachi Chemical Diagnostics, Inc. · Mar 2013
ACE ALKALINE PHOSPHATASE REAGENT, ACE AMYLASE REAGENT, ACE LDH-L REAGENT
K113436 · Alfa Wassermann · Jul 2012
ELITTECH CLINICAL SYSTEMS ALP IFCC SL
K113269 · Elitechgroup · Dec 2011
K131351 · ACE ALKALINE PHOSPHATASE REAGENT, AMYLASE REAGENT, ALT REAGENT, AST REAGENT
Download PDF FDA Summary Alfa Wassermann Diagn…